baber/WOPTO huggingface dataset:
Patent DE-602004013457-T2 (DE)
Inventor: LANGELAAR GERRIT C
IPC: G06T1/00
Filed: 2004-10-06
Granted: 2009-01-29
Abstract: Watermark detectors have a buffer in which a number of image tiles are folded and accumulated prior to computing the correlation between buffer contents and the watermark pattern being looked for. The intention of the folding and accumulation process is to average out the video content while accumulating the embedded watermark energy. This no longer appears to hold for strongly compressed video, such as DIVX, which exhibits a lot of artificial noise and undesired similarity (block patterns). As a result thereof, correlation peaks are often below the threshold. In a similar manner, the compression affects scale detection. According to this invention, only frames (or parts thereof) that are not so heavily compressed and therefore have a high probability of carrying enough watermark energy are folded and accumulated. To this end, a quality metric is calculated, the quality metric being indicative of the degree of compression of the data. The quality metric may be calculated based on the compressed data itself or derived from the decompressed base-band data. An advantageous example is the number of non-zero DCT coefficients of a (residue) frame. A determination is then made as to whether to exclude the frame (or part thereof) from the watermark decode process. The quality metric may also be used to select data for use in a scale detection process.
Patent DE-602005002598-T2 (DE)
Inventor: GANDOLFI PAOLO
IPC: G01R31/12
Filed: 2005-10-07
Granted: 2008-06-26
Abstract: Instrument for detecting and analysing partial discharges in electrical machines in which a peak detector circuit (22) receives in input a signal correlated to the difference between two signals picked up from a winding of an electrical machine and reciprocally offset in time. According to the invention, it is envisaged an inhibitor circuit (35) associated to the peak detector and adapted to inhibit, following the detection of a first peak corresponding to a partial discharge, the detection of other peaks in a silencing interval (Tsleep) variable at will by the operator.
Patent DE-602005003707-T2 (DE)
Inventor: MIRAND PIERRE
IPC: B64D43/02
Filed: 2005-05-23
Granted: 2008-11-27
Abstract: The aircraft has a L shaped atmospheric disturbances measuring and/or detecting optical device (11) operating in pressurized area and placed, in front zone of the aircraft, between nose of the aircraft and a landing gear case. The device is surrounded by a case structure (18) that supports pressurization efforts, where the structure is covered by a streamlined fairing (13).
Patent DE-602005003835-T2 (DE)
Inventor: MONTALBANO GIUSEPPE
IPC: H04B17/00
Filed: 2005-07-11
Granted: 2008-04-17
Abstract: The estimated power levels that are used to estimate a signal-to-interference ratio (SIR) are filtered so as to minimize the mean-square error (MSE) of the estimated power estimates. First order infinite impulse response (IIR) filters are used to filter both the signal power estimates and the noise power estimates. Optionally, estimates of the average signal power and average interference power are filtered using Weiner linear prediction filters. The SIR estimates are suitable for use in a transmission channel that includes fading as well as interference, and are suitable for use in BPSK, QPSK, and other modulation systems.
Patent DE-602005004267-T2 (DE)
Inventor: DEKKERS JOSEPHUS HUBERTUS
IPC: C08K9/00
Filed: 2005-03-11
Granted: 2008-07-24
Abstract: Articles having an exterior surface comprising an inorganic biocidal agent and a first thermoplastic resin can provide a good combination of biocidal activity and physical properties. The biocidal activity of an article or multi-layer article can be enhanced by texturizing the exterior surface of the article or multi-layer article. The surface can be texturized by calender with a textured roll, mechanical or chemical abrading, or molding in a textured mold.
Patent DE-3688900-T3 (DE)
Inventor: MURRAY MARK J
IPC: C12N15/57
Filed: 1986-06-26
Granted: 1998-06-10
Abstract: Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C and recombinant transfer vectors comprising these sequences are disclosed. Methods are disclosed for producing a protein which has substantially the same biological activity as human protein C. The protein, which may be in the form of activated protein C, is produced by mammalian host cells transfected with a plasmid capable of integration in mammalian host cell DNA. The plasmid includes a promoter followed downstream by a nucleotide sequence which enoodes a protein having substantially the same structure and/or activity as human protein C, the nucleotide sequence being followed downstream by a polyadenylation signal.
Patent DK-1113248-T3 (DK)
Inventor: DAVIES LAWRENCE
IPC: G01F1/84
Filed: 2000-11-08
Granted: 2011-10-24
Abstract: The Coriolis measurement tube (1) is made of ceramic.
Patent DK-1083224-T3 (DK)
Inventor: NOTEBORN MATHIEU HUBERTUS MARI
IPC: A61K38/00
Filed: 2000-09-01
Granted: 2007-04-10
Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with apoptin, especially in those cases wherein p53 is (partly) non-functional.  <IMAGE>
Patent DK-1077218-T3 (DK)
Inventor: SCOLASTICO CARLO
IPC: C07B53/00
Filed: 2000-07-27
Granted: 2007-09-24
Abstract: The present invention discloses compounds of formula (I)  <CHEM> wherein n is the number 0, 1 or 2. There are also disclosed processes for the preparation of said compounds, together with methods for treating pathologies related to an altered  alpha v beta 3 integrin-mediated cell attachment, in particular wherein the inhibition of angiogenesis is desired, for example in tumors, also associated with metastasis.
Patent DK-1140925-T3 (DK)
Inventor: MEWSHAW RICHARD ERIC
IPC: A61K31/5377
Filed: 2000-01-06
Granted: 2003-08-11
Abstract: Compounds are provided which have formula (1) wherein: R is hydrogen, alkyl of 1 to 6 carbon atoms, phenyl, or substituted phenyl; X and Y are each, independently, hydrogen, halogen, cyano, or alkoxy of 1 to 6 carbon atoms; and m is 1 to 5; or a pharmaceutically acceptable salt thereof useful in the treatment of neurological diseases caused by disorders of the serotonin-affected neurological systems.
Patent DK-1229922-T3 (DK)
Inventor: FAIRCLOTH GLYNN THOMAS
IPC: A61P35/00
Filed: 2000-11-15
Granted: 2007-10-08
Abstract: Aplidine demonstrates considerable promise in phase (I) clinical trials for treatment of tumors, and various dosing regimes are given. Tumor reduction has been observed in several tumor types including renal carcinoma, colorectal cancer, lung carcinoid, medullary thyroid carcinomas and melanoma. It has also been found that aplidine has a role in inhibiting angiogenesis, complementing the anti-tumor activity.
Patent DK-1340368-T3 (DK)
Inventor: BOURSIER ARNAUD
IPC: H04N5/00
Filed: 2000-11-17
Granted: 2008-08-04
Abstract: A digital television receiving system having a security mechanism which simultaneously handles two or more separate television program signals is described. The system includes a plurality of digital television receiver mechanism for receiving a plurality of separate digital television program signal transport streams. The system also includes a multiplexer mechanism coupled to the digital television receiver mechanisms for tagging and multiplexing the received program signal transport streams into a single combined signal transport stream. The combined transport stream is supplied to a security mechanism which limits usable access to the combined stream to authorized users. The system further includes a demultiplexer mechanism for receiving an access-allowed combined transport stream from the security mechanism and demultiplexing the combined transport stream into separate transport streams corresponding to the separate transport streams received by the receiver mechanisms. The system also includes circuitry responsive to at least one of the demultiplexed transport streams for supplying image signals to a television display mechansim for producing television images.
Patent DK-1276609-T3 (DK)
Inventor: LONGO EUGENIO
IPC: B32B27/08
Filed: 2001-02-27
Granted: 2006-08-14
Abstract: A multi-layer, thermoplastic film bi-axially oriented at a stretching ratio >= to about 3.0:1 in the machine direction and at a stretching ratio >= about 6.0:1 in the transverse direction, which film comprises a layer a) comprising at least 50 wt. % of a crystalline or partially crystalline co-polyamide characterized by a T<SUB>g</SUB><=100° C. and at least one outer heat-sealing layer b) comprising a polyolefin, said film being further characterized in that it has a % free shrink at 100° C.<=3 in each direction.
Patent DK-1290444-T3 (DK)
Inventor: SNODGRASS H RALPH
IPC: C12Q1/6809
Filed: 2001-06-14
Granted: 2010-01-18
Abstract: This invention provides methods and systems for identifying and typing toxicity of chemical compositions, as well as for screening new compositions for toxicity. The invention involves detecting alterations in gene or protein expression and hence establishing molecular profiles in isolated mammalian LSCs contacted with various chemical compositions of known and unknown toxicities, and correlating the molecular profiles with toxicities of the chemical compositions.
Patent DK-1328577-T3 (DK)
Inventor: CORNISH ALEXANDER
IPC: C08K5/00
Filed: 2001-10-05
Granted: 2006-05-15
Abstract: The invention relates to a method for inhibiting the growth of microorganisms in a latex, especially a sterically stabilised or cationic stabilised latex and to a composition for use in the method comprising a polymeric biguanide and an isothiazolinone of the Formula (1).
Patent DK-1404319-T3 (DK)
Inventor: MIURA MICHIKO
IPC: A61K51/04
Filed: 2002-06-05
Granted: 2006-07-31
Abstract: The present invention covers radiosensitizers containing as an active ingredient halogenated derivatives of boronated porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron-capture therapy and photodynamic therapy. The present invention also covers methods for using these radiosensitizers in tumor imaging and cancer treatment.
Patent DK-1375787-T3 (DK)
Inventor: NABB PETER
IPC: E05B15/02
Filed: 2003-06-26
Granted: 2018-04-09
Abstract: A striking plate assembly (1) for a lock to be secured to a frame comprising a striking plate (2), which has a bolt opening (3) arranged in the front surface (2.1) thereof and to which a bolt casing (4) is secured, inside of which casing a body part (5) providing a bolt housing is movably adapted, the bolt housing (5.1) itself forming a stationary part thereof, and an adjusting screw arrangement operated from the front surface (2.1) of the striking plate for adjusting the bolt housing (5.1) with respect to the striking plate (2), whereby the adjusting screw arrangement is arranged to be supported on one hand by the striking plate (2) and on the other hand by the bolt casing (4). The adjusting screw arrangement comprises guiding members (7, 8), which are arranged to affect directly the body part (5) so that they adjust the position of the bolt housing (5.1) with respect to the striking plate (2) and its bolt opening (3) and lock the current position of the body part (5) of the lock housing. <IMAGE>
Patent DK-1523335-T3 (DK)
Inventor: GLAUSCH ALEXANDRA
IPC: A61K47/36
Filed: 2003-07-14
Granted: 2007-01-29
Abstract: An injectable depot formulation comprising crystals having structure (I) wherein R is (FII) and the X50 value of the crystals is from 1 to 200 microns. Depot formulations containing crystals of iloperidone or its metabolites have the following advantages: (i) release of the crystals in plasma can be correlated with the size of the crystals; (ii) absorption of the crystals in plasma can be correlated with the size of the crystals; (iii) the particle size of the crystals can be controlled by crystal engineering and/or milling; and (iv) the crystals are stable upon storage, and stable to sterilization procedures, such as gamma irradiation.
Patent DK-1568709-T3 (DK)
Inventor: METZNER HUBERT
IPC: A61P7/04
Filed: 2005-02-12
Granted: 2011-08-22
Abstract: Purifying fibrinogen solutions comprises removing contaminating proteins by negative chromatography and/or negative adsorption using a cation exchanger, hydrophobic gel and/or dye gel. An independent claim is also included for a fibrinogen preparation produced as above. ACTIVITY : Hemostatic; Vulnerary. MECHANISM OF ACTION : None given.
Patent DK-1723337-T3 (DK)
Inventor: YAROGLU TOLGA
IPC: F04B39/02
Filed: 2005-02-09
Granted: 2009-08-31
Abstract: This invention relates to a compressor (1), preferably used in refrigerators, which comprises a crank (5) incorporating channels (17) whereby the lubrication is improved.
Patent DK-1773277-T3 (DK)
Inventor: PAHLBERG OLOF
IPC: B65D81/00
Filed: 2005-06-16
Granted: 2009-01-12
Abstract: A pharmaceutical container with an improved peelable seal is provided, wherein the container is made of a flexible polymeric film and comprises at least one peelable seal comprising at least two substantially straight sections (7, 8) which are connected by a rupture zone (5), characterized in that the rupture zone (5) of the peelable seal is curved over its whole length between the straight sections (7, 8). The container is used for storing pharmaceutical substances, solutions for dialysis, solutions for infusion and/or agents for nutrition.
Patent DK-1769289-T3 (DK)
Inventor: BOTHE CHRISTOPH
IPC: G04F10/10
Filed: 2005-07-12
Granted: 2010-06-07
Abstract: The invention relates to a method for the highly accurate digital measurement of an analogue signal and to a corresponding device. A measuring clock pulse (f<SUB>M</SUB>) is generated from a clock pulse signal (f<SUB>T</SUB>). In a first calibration step, a capacitor (C) is charged with a constant current (I<SUB>K</SUB>) during the entire period of the clock pulse signal (f<SUB>T</SUB>). The charge voltage is maintained and is converted into a digital comparison number. In a subsequent measuring step, a first portion (T<SUB>1</SUB>) of the duration of the analogue signal is determined as an appropriately selected, whole-numbered multiple (m) of the duration (T<SUB>0</SUB>) of the period of the clock pulse signal (f<SUB>T</SUB>). The capacitor (C) is charged with the same constant current (I<SUB>K</SUB>) from the end of the first portion (T<SUB>1</SUB>) until the occurrence on the specified flank of the received signal (f<SUB>E</SUB>). The charge voltage is maintained and converted into a digital measuring number. The measuring number is divided by the comparison number, which permits the duration of a second portion (T<SUB>2</SUB>) of the analogue signal to be calculated as a fraction of a measuring clock pulse period. The measured value of the analogue signal is calculated from the first portion (T<SUB>1</SUB>) and the second portion (T<SUB>2</SUB>).
Patent DK-1805305-T3 (DK)
Inventor: RUITERS MARCEL HERMAN JOSEF
IPC: C12N15/88
Filed: 2005-10-20
Granted: 2009-11-23
Abstract: Vehicle for the transport of a chosen molecule to a cell, comprising a SAINT-molecule which is bound to the chosen molecule by means of an electrostatic interaction, in which the SAINT-molecule is coupled to the linker molecule and the linker molecule is coupled to the cell specific ligand and in which the SAINT-molecule is covalently bound to the linker molecule.
Patent DK-1743709-T3 (DK)
Inventor: GRUENKE PETER
IPC: B05D7/22
Filed: 2006-07-03
Granted: 2010-11-22
Abstract: Method involves heating of container (2) preferably in heating oven on a specific temperature from 250 to 300[deg]C. A duroplastic synthetic material is applied on the inner wall of the preheated container, which rotates about its longitudinal axis. After partial cooling, if necessary, a duroplastic synthetic material is applied on outer side of intermediate storage (5) at temperatures from 165 to 250[deg]C after which container is mounted, installed and tested. An independent claim is also included for the pressure vessel.
Patent DK-1927275-T3 (DK)
Inventor: ZEININGER HEINRICH
IPC: B41N1/24
Filed: 2006-08-25
Granted: 2011-01-10
Abstract: The printing template (2) of an SMT process includes a metallic template body (2a) with clearances (3) corresponding to a desired printing structure. A printing material is to be applied through these clearances (3) to a plate that is to be joined onto the printing template from below. To prevent the printing material from adhering in the region of the clearances (3), the metallic template body (2a) is to be provided with a thin coating (6) of a metal-alkoxide coating material, the surface energy of which is reduced by chemical bonding of at least one organic component. The coating may be performed in particular by means of a sol-gel process.
Patent DK-2048917-T3 (DK)
Inventor: FORSSEN JOHAN
IPC: H05B44/00
Filed: 2007-10-09
Granted: 2012-05-14
Abstract: A method of feeding electric power to an LED (4) in an airfield lighting unit (7). The method comprises the steps of: feeding a constant alternating current (I s ) to a rectifier (40), rectifying the alternating current (I s ) to a rectified current (I r ), pulse width modulating the rectified current (I r ), charging a capacitor (43) with the pulse width modulated rectified current (I r ), and feeding the LED (4) with power from the capacitor (43).
Patent DK-2109623-T3 (DK)
Inventor: SIMARD JOHN
IPC: C07K16/24
Filed: 2007-05-22
Granted: 2012-01-30
Abstract: Treating a patient with anti-IL-1α antibody or anti-IL-1α immunization s a cancer treatment.
Patent DK-2267142-T3 (DK)
Inventor: AKIMOTO KENGO
IPC: A23L33/00
Filed: 2003-10-09
Granted: 2015-10-12
Abstract: A process for producing oil comprising a highly unsaturated fatty acid as a constituent fatty acid. 
A microorganism such as Mortierella is cultured in a medium containing nitrogen source at a concentration of 2 to 15% in a culture tank equipped with an agitation impeller. The nitrogen source is previously sterilized at a pH of not more than 5.
Patent DK-2503429-T3 (DK)
Inventor: SPAULDING JEFF
IPC: G11B33/12
Filed: 2011-04-26
Granted: 2018-08-27
Abstract: A computer component mounting assembly includes a base plate, a carrier configured to receive a vibration sensitive computer component, and a vibration isolation system including three isolators connecting the carrier to the base plate. The three isolators are spaced at different angular positions around a central point, and the vibration isolation system is configured such that the vibration isolation system has a rotational natural frequency about the central point of less than 45 Hz.
Patent DK-2386817-T3 (DK)
Title: ballistic armor
Inventor: RAVID MOSHE
IPC: F41H5/04
Filed: 2006-04-18
Granted: 2015-11-02
Abstract: A composite armor plate with a layer of pellets in a binder matrix, the pellets having domed front and planar back end and a reduced weight. A method of producing the plate comprises providing front and back layers, applying binder material to the pellets and the layers, and heating the binder material to form the matrix and bind the front and back layers thereto. Each pellet may be coated with a primer adapted to facilitate the binding.
Patent DK-2777283-T3 (DK)
Inventor: MARPE DETLEV
IPC: H04N19/96
Filed: 2012-11-09
Granted: 2018-04-16
Abstract: The way of predicting a current block by assigning constant partition values to the partitions of a bi-partitioning of a block is quite effective, especially in case of coding sample arrays such as depth/disparity maps where the content of these sample arrays is mostly composed of plateaus or simple connected regions of similar value separated from each other by steep edges. The transmission of such constant partition values would, however, still need a considerable amount of side information which should be avoided. This side information rate may be further reduced if mean values of values of neighboring samples associated or adjoining the respective partitions are used as predictors for the constant partition values.
Patent DK-3718564-T3 (DK)
Inventor: FUNG SEK CHUNG MICHAEL
IPC: A61K39/00
Filed: 2004-12-23
Granted: 2023-11-06
Abstract: The present invention relates to ant-IL-13 antibodies that bind specifically and with high affinity to both glycosylated and non-glycosylated human IL13, does not bind mouse IL13, and neutralize human IL13 activity at an approximate molar ratio of 1:2 (MAb:IL13). The invention also relates to the use of these antibodies in the treatment of IL13-mediated diseases, such as allergic disease, including asthma, allergic asthma, non-allergic (intrinsic) asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, eczema, urticaria, food allergies, chronic obstructive pulmonary disease, ulcerative colitis, RSV infection, uveitis, scleroderma, and osteoporosis.
Patent DK-0411615-T3 (DK)
Inventor: KESTER JEFFREY ALAN
IPC: A61P25/28
Filed: 1990-08-01
Granted: 1994-01-24
Abstract: 4-(N-Substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as centrally acting muscarinic agents and are useful as analgesic agents for the treatment of pain, as sleep aids and as agents for treating the symptoms of senile dementia, Alzheimer's disease, Huntington's chorea, tardive dyskinesia, hyperkinesia, mania, or similar conditions of cerebral insufficiency characterized by decreased cerebral acetylcholine production or release.
Patent DK-0413282-T3 (DK)
Inventor: OGLE JOHN SELDON
IPC: H01J37/32
Filed: 1990-08-11
Granted: 1998-08-24
Abstract: An apparatus for producing a planar plasma in a low pressure process gas includes a chamber (12) and an external planar coil (20). Radiofrequency resonant current is induced in the planar coil which in turn produces a planar magnetic field within the enclosure. The magnetic field causes circulating flux of electrons which in turn produces a planar region of ionic and radical species. The system may be used for plasma treatment of a variety of planar articles, typically semiconductor wafers which are oriented parallel to the plasma within the enclosure.
Patent DK-0382687-T3 (DK)
Inventor: TURCONI MARCO
IPC: C07D401/06
Filed: 1990-02-05
Granted: 1996-02-05
Abstract: Pharmacologically active benzofused-N-containing heterocycle derivatives are described as muscarinic receptor blocking agents useful for the treatment of gastrointestinal and respiratory tract disorders of the following formula: <CHEM>  wherein  R represents H or C1-6 alkyl; R1 and R2 represent H, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 alkoxycarbonyl, carboxyl, hydroxy, nitro, cyano, optionally C1-4 alkyl mono- or disubstituted carbamoyl, optionally C1-4 alkyl mono- or disubstituted amino, C1-6 acylamino, C1-4 alkoxy carbonylamino, C1-6 alkylsulphynyl, C1-6 alkylsulphonyl, C1-6 acyl;  R3 represents H, C1-6 alkyl, aryl, aralkyl or it may be absent;  A represents CO, C = S, S -> O or <CHEM> B represents nitrogen when R3 is absent and the B-D bond is single, or it is carbon;  D represents CO, CH2-CH2, <CHEM> when the B-D bond is single, or D is C-R when the D-B bond is double, in which R4 represents H, C1-6 alkyl, aryl, aralkyl, hydroxy, C1-4 alkoxy and R5 represents H;  X represents oxygen, N-R or it is absent;  Y represents a basic group selected from: <CHEM> in which n is 2 or 3; p is 0 or 1 at the same time or not; q is 0, 2 or 3; R6 and R7 may be at the same time or not H, C1-4 alkyl, aralkyl or, when R7 is H or C1-4 alkyl, R6 may be <CHEM>  in which R8 represents H, C1-4 alkyl or amino. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.